Takeda, TWi have ‘no right’ to discovery stay in pharma suit, US judge says
By Chris May ( October 16, 2025, 22:09 GMT | Insight) -- Takeda Pharmaceuticals and TWi Pharmaceuticals won’t be able to pause burden-free, relevant document discovery requests from grocers bringing a pay-for-delay lawsuit involving the acid reflux treatment Dexilant and its generic equivalents, a California federal judge said today.Takeda Pharmaceuticals and TWi Pharmaceuticals won’t be able to pause burden-free, relevant discovery requests from grocers bringing a pay-for-delay lawsuit involving the acid reflux treatment Dexilant and its generic equivalents, a California federal judge said today....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.